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These were the oxazolidinones
and a group of quinolone
derivatives. The oxazolidinones,
bacteriostatic rather than
bactericidal, were expensive: it
had cost Rhone-Poulenc Rorer
$0.5 billion to bring Synercid to
the market, and this outlay was
reflected in the cost of treatment
– up to $250 a day. It was agreed
that neither the oxazolidinones
nor the quinolones, licensed for
human use, would be given to
animals, but before long the
agricultural industry had got its
hands on analogues of both,
either for growth-enhancement or
for therapy.
Before long animals around the
world were found to be
abundantly infested with
pathogens, with Salmonella or
Campylobacter. (The egregious
UK agriculture minister, Edwina
Curry, lost her job for uttering the
unpalatable truth.)
In the US consumer groups and
the Center for Disease Control,
which had for years been
campaigning ceaselessly against
indiscriminate use of antibiotics,
demanded the withdrawal of
quinolones from agriculture. As
ever, the powerful agricultural
lobby lied and intrigued to protect
profits.
The story of the antibiotics is a
melancholy litany of folly and
greed. Human nature will not be
gainsaid. As Kipling has it,
There are only four things
certain since Social Progress
began –
That the Dog returns to his
vomit and the Sow returns to her
Mire,
And the burnt Fool’s bandaged
finger goes wabbling back to the
Fire …
Attempts to find new antibiotic
substances are not now, it
seems, a matter of high priority
for Big Pharma. The cost of
bringing drugs to market has
risen alarmingly, and it is
medication for chronic maladies,
rather than single-shot cures for
infections, that will sustain the
profits.
Tuberculosis is still to a large
extent a disease of destitute
populations, though that is
beginning to change. The focus,
Shnayerson and Plotkin reveal,
has in large measure shifted to
vaccines, assisted by genomic
strategies and improved
procedures for rapid identification
of the agents of infection. And
perhaps the whole notion of
eliminating the wily pathogens
once and for all was
misconceived: might it not be
better to treat infections
conservatively, for then the
evolutionary advantage will rest
with more benign strains, which
do not kill their hosts?
There is also now much
research on peptides to inhibit
the binding of the pathogen to its
cell receptors. These have been
sought in such improbable
hiding-places as the saliva of the
Komodo dragon. Finally, the long-
neglected possibilities of
bacteriophages are once more
being taken seriously.
It was a revelation to me that
these specialised viruses have
been in therapeutic use in the
countries of the former Soviet
imperium ever since their
discovery nearly a century ago, or
that they reputedly saved untold
numbers of lives on the
battlefields of the Second World
War. Research into phage therapy
has somehow continued in the
decayed and impoverished
laboratories of Eastern Europe,
most notably the Eliava Institute
in ravaged Tbilisi.
Perhaps, paradoxically, it is the
shadow of Al Qaeda and those
elusive envelopes of anthrax
bacilli that will now liberate the
money and talent needed to
combat the depredations of
man’s ancient unicellular
enemies.
All this and more you will learn
from The Killers Within, which
serves at once as a wholly
absorbing tale of scientific
detection, a lesson in biology, a
tableau of grand guignol and a
powerful admonition on the
misuse of science. Read, learn
and ponder.
Walter Gratzer is at the Randall Centre
for Molecular Mechanisms in Cell
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Street, London SE1 1UL, UK.
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What are they? Polycomb group
(PcG) proteins are a set of general
transcriptional repressors
essential for development in many
organisms. They are best known
as repressors that restrict Hox
gene expression along the
anterior–posterior animal body
axis. About 15 PcG repressors
have been identified. They are
generally not related by shared
domains or structural motifs, but
form a family based on common
function.
Why are they important? PcG
proteins organize target gene
chromatin to maintain repressed
states for long periods of time and
through many cell divisions. So
they provide an important way to
keep genes shut off during
development or through
successive life stages. This type
of epigenetic phenomenon has
been called transcriptional or
chromatin memory.
Where does the name come
from? When PcG proteins are
disrupted in Drosophila, Hox
genes are derepressed in specific
body regions. For example, Hox
proteins normally restricted to the
abdomen become expressed
ectopically in the head and thorax.
This transforms body segments to
a more posterior character. In the
extreme case, all segments mimic
the hindmost abdominal segment,
which produces a developmental
dead end! Weak PcG mutations
often make the second and third
pairs of legs develop like the first
pair. Normally, the first pair of
male legs are uniquely decorated
with a bristly structure called the
sex comb, used for hugging
females. So weak PcG mutants
have extra sex combs, sometimes
on all six legs (and are
presumably better huggers).
Hence the name Polycomb.
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How were they discovered?
Most Drosophila PcG genes were
identified by mutations that
transform body segments. The
namesake group member,
Polycomb, was discovered by
Pamela Lewis in 1947. Many other
PcG genes were found by Ian
Duncan and Gerd Jürgens in the
mid-1980s. Cloning of fly PcG
genes led to identification of
homologs in mice and humans.
Worm PcG genes were found
through mutations affecting
germline development and many
plant PcG genes were identified
by mutations affecting seed or
flower development.
Are they loners or team players?
PcG repressors work together in
protein complexes. Two major PcG
complexes from Drosophila, called
the ESC-E(Z) complex and
Polycomb repressive complex 1
(PRC1), are depicted in Figure 1.
Core subunits of both complexes
are conserved in mammals. Several
ESC-E(Z) complex components are
also conserved in worms and
plants. Although PcG repressors
sort into distinct complexes, loss of
one member can single-handedly
disrupt gene repression. So it’s
generally all-for-one and one-for-all.
How do they work? Complete
mechanisms are not known, but
recent studies suggest the model
illustrated in Figure 1. ESC-E(Z)
complexes from flies and humans
have histone H3
methyltransferase activity, which
covalently modifies specific tail
lysine residues. The methylated
H3 tails may help attract PRC1 to
local nucleosome arrays. As PRC1
binding to arrays can block
subsequent binding and action of
an ATP-dependent chromatin
remodeling complex, it may
repress through a noncatalytic
mechanism that restricts access
to nucleosomes.
A quiet neighborhood can be
key for life. Knockout mutations
in fly or mouse PcG genes are
generally lethal. When PcG
chromatin silencing goes awry,
defects are caused by mis-
expression of Hox and other
developmental control genes,
which leads to the next
question…
Are there other PcG roles? Yes,
PcG proteins are required for many
processes besides axial control of
Hox genes. In mammalian systems,
PcG repressors are implicated in
hematopoiesis, X inactivation, pre-
Hox embryonic development, and
control of cell proliferation. PcG
proteins are also linked to cancers
of the immune system and prostate.
This emphasizes the importance of
maintaining transcriptionally
repressed states and of studying
PcG chromatin mechanisms in
many biological systems.
Where do we go from here? A
major puzzle concerns how PcG
repression is propagated in
actively dividing cells. Somehow
the PcG-repressed state is
preserved through wholesale
chromatin changes that
accompany DNA replication and
mitosis. How this happens in
molecular terms is unclear and
provides a key challenge for
understanding PcG mechanisms
in the future.
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Figure 1. A model for sequential action of PcG complexes in chromatin.
The cartoon depicts the two PcG complexes ESC-E(Z) and PRC1, with core subunits
identified, showing their suggested effects on a target nucleosome array. The ESC-E(Z)
complex methylates histone H3 tails, using catalytic activity supplied by the E(Z) SET
domain. PRC1 binds to the methylated oligonucleosomes and represses transcription
by restricting access of chromatin remodeling complexes and/or other activating factors.
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